Transnasal Sphenopalatine Ganglion Block for Postoperative Pain and Recovery in Tonsillectomy (TONwoPA)

Study acronym: TONwoPA
StatusCompleted
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Jun 1, 2025 to Aug 30, 2025 Show 8 more changesShow less
    • Trial status changed: Enrolling by Invitation → Completed
    • Primary completion date changed from estimate of Jun 1, 2026 to Aug 15, 2026
    • Enrollment target: estimated 28 to confirmed 26
    • Study completion date changed from estimate of Jun 15, 2026 to Aug 30, 2026
    • Secondary endpoints: details revised at 1 of 2 entries
    • Study description revised
    • Publications: details revised at 25 of 26 entries
    • Eligibility criteria expanded, about 2 words
  2. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
The aim of this clinical trial is to evaluate the effectiveness of transnasal transmucosal sphenopalatine ganglion block in reducing post-tonsillectomy pain. The study also investigates its impact on rescue analgesic requirements and postoperative recovery by comparing 5% lidocaine with placebo. Participants will receive a transnasal transmucosal sphenopalatine ganglion block with either 5% lidocaine or placebo (saline). Postoperative pain levels and opioid consumption will be monitored during the first 24 hours after surgery. In addition, length of hospital stay, the occurrence of primary and secondary post-tonsillectomy hemorrhage up to 14 days, unplanned hospital readmissions after discharge, and patient satisfaction on postoperative day 14 will be assessed.
Trial Details
NCT Number NCT07370129
Lead Sponsor Ankara University
Conditions
(from sponsor)		 Post Tonsillectomy Pain, Post Operative Analgesia, Opioid Consumption, Sphenopalatine Ganglion Block, Tonsillar Surgery Complications
Enrollment 26 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov